SCHEMBL30784055

SCHEMBL30784055

Cc1cc(C(C)N)c2nc(N3CCCCC3)n(C)c(=O)c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 1/20 0.48
▸ AKT2 P31751 1/20 0.48
▸ AKT3 Q9Y243 1/20 0.48
▸ CRHR1 P34998 1/20 0.48
▸ ALDH1A1 P00352 5/20 0.39
▸ KMT2A Q03164 2/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ DRD2 P14416 4/20 0.34
▸ DRD4 P21917 4/20 0.34
▸ DRD3 P35462 4/20 0.34
▸ DPP4 P27487 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ CASP1 P29466 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30784478 0.90 AKT1 (0.44) AKT1AKT2AKT3CRHR1HTT
SCHEMBL30784348 0.90 AKT1 (0.47) AKT1AKT2AKT3CRHR1KMT2A
SCHEMBL30783721 0.90 AKT1 (0.47) AKT1AKT2AKT3CRHR1ALDH1A1
SCHEMBL30783583 0.90 AKT1 (0.47) AKT1AKT2AKT3CRHR1KMT2A
SCHEMBL30721019 0.90 AKT1 (0.47) AKT1AKT2AKT3CRHR1ALDH1A1
SCHEMBL25361160 0.89 AKT1 (0.48) AKT1AKT2AKT3CRHR1ALDH1A1
SCHEMBL30495111 0.89 AKT1 (0.48) AKT1AKT2AKT3CRHR1ALDH1A1
SCHEMBL30494961 0.89 AKT1 (0.50) AKT1AKT2AKT3CRHR1ALDH1A1
SCHEMBL25359802 0.89 AKT1 (0.50) AKT1AKT2AKT3CRHR1ALDH1A1
SCHEMBL25360674 0.89 AKT1 (0.52) AKT1AKT2AKT3CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026424-A1 QUINAZOLINONE DERIVATIVES AS AND RELATED USES BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback